癌变·畸变·突变 ›› 2006, Vol. 18 ›› Issue (1): 58-060.doi: 10.3969/j.issn.1004-616x.2006.01.017

• 肿瘤防治 • 上一篇    下一篇

食管癌患者外周血淋巴细胞替代肿瘤细胞体外药敏试验相关性研究

艾 军;梁索源;单保恩;何兰欣;任金荣   

  1. 河北医科大学第四医院肿瘤所,河北 石家庄 050011
  • 收稿日期:2005-01-11 修回日期:2005-05-30 出版日期:2006-01-30 发布日期:2006-01-30
  • 通讯作者: 艾 军

Correlation Study on the Chemosensitivity in vitro by Peripheral Blood Lymphocyte and Tumor Cells of Patients with Esophageal Carcinoma

AI Jun;LIANG Suo-yuan;SHAN Bao-an;HE Lan-xin;REN Jing-rong   

  1. Hebei Cancer Institute The Four Hospital of Hebei of Medical University ,Shijiazhuang 050011, Hebei,China
  • Received:2005-01-11 Revised:2005-05-30 Online:2006-01-30 Published:2006-01-30
  • Contact: AI Jun

摘要: 背景与目的:探讨食管癌患者外周血淋巴细胞与肿瘤细胞体外药敏试验的相关性。方法与材料:采用四甲基偶氮唑蓝(3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide ,MTT)法体外药敏试验,检测了32例食管癌患者外周血淋巴细胞和肿瘤细胞对9种临床常用化疗药物的敏感性。结果:食管癌患者外周血淋巴细胞和肿瘤细胞对5-氟脲嘧啶(5-fluorouracilum ,5-Fu)、顺铂(Diamminedich- loroplatinum,DDP)、卡铂(Carboplatinum,CBP)、氨甲喋呤(Methotrexate, MTX)、环磷酰胺Cyclophosphamide,CTX)敏感;对阿霉素 (Adriamycin ,ADM)、长春新碱(Vincristin,VCR)不敏感;对足叶乙甙(Etoposide,Vp16)和吡柔比星(Pirarubicin, THP)的敏感性不同。结论: 食管癌患者肿瘤细胞和外周血淋巴细胞对上述化疗药物敏感率差异无统计学意义。食管癌外周血淋巴细胞化疗药敏检测对临床选择化疗药物具有重要参考价值。对无法取得肿瘤标本的患者,可用外周血淋巴细胞替代癌细胞进行药敏检测。

关键词: 外周血淋巴细胞, 药物敏感实验, 肿瘤细胞, 食管癌

Abstract: BACKGROUND & AIM: To study the correlation of chemosensitivity no peripheral blood lymphocyte and tumor cells . MATERIAL AND METHODS: 3-( 4,5-dimethylthiazol-2-yl )-2, 5- diphenyltetrazolium bromide (MTT) method was used to test the sensitivity of the peripheral blood lymphocyte and the tumor cells of 32 patients with esophageal carcinoma to 9 kinds of anti-cancer drugs. RESULTS: The peripheral blood lymphocyte and the tumor cells were sensitive to chemotherapeutic drugs of 5-fluorouracilum (5-Fu),diamminedichloroplatinum(DDP),carboplatinum (CBP),methotrexate (MTX) and cyclophosphamide(CTX),but not sensitive to adriamycin ( ADM) ,vincristin (VCR); There was alack of correlation by lymphocyte and tumor cells to Vp-16 , THP. CONCLUSION:There were no statistical differences in the rate of sensitivity to the above-mentioned drugs between the peripheral blood lymphocyte and the tumor cells (P>0.05).Peripheral blood lymphocyte may replace tumor cells in clinical chemosensitivity test

Key words: peripheral blood lymphocyte, tumor cell, chemosenaitivity test, esophageal carcinoma

中图分类号: